Study sheds more light on rate of rare blood clots after Oxford-AstraZeneca vaccine
Thromboembolism and the Oxford-AstraZeneca vaccine
6 May 2021Covid-19: Two doses of Pfizer vaccine are “highly effective” against infection, hospital admission, and death, study finds
6 May 2021Study sheds more light on rate of rare blood clots after Oxford-AstraZeneca vaccine
A large study from Denmark and Norway published by The BMJ today sheds more light on the risk of rare blood clots in adults receiving their first dose of the Oxford-AstraZeneca COVID-19 vaccine.
